Citations

Showing 10 of 108104 citations.

Impact of invasive aortic pulse pressure on coronary microvascular endothelial-independent dysfunction and on mortality in non-obstructive coronary artery disease
Park, Hyun Woong , Ahmad, Ali , Lerman, Lilach O. , Lerman, Amir , Corban, Michel , Lerman, Lilach O , Lerman, Amir , Toya, Takumi , Ӧzcan, Ilke

Mayo Clinic

Open Heart | February 1, 2022 | Volume: 9 | Issue: 1 | Pages: e001925

10.1136/openhrt-2021-001925 | PMID 35105720 Get It

Background Pulse pressure (PP), a raw index of arterial stiffness, is inversely related to coronary microvascular function, even among patients with non-obstructive coronary artery disease (CAD), as per non-invasive studies. We aimed to determine whether invasive aortic PP is associated with coronary microvascular endothelial dysfunction (CMED) and/or coronary microvascular endothelial independent dysfunction (CMEID) in patients with non-obstructed CAD. Methods We retrospectively analysed a cohort of 1894 patients (mean age, 51.2 years; 1261 (66.6%) women) who presented with chest pain and non-obstructive CAD (angiographic stenosis <50%); coronary vasoreactivity was assessed in the mid-left anterior descending artery. The patients were classified based on whether aortic PP was high (≥50 mm Hg). CMEID was defined as abnormal coronary flow reserve (<2.5) or hyperaemic myocardial resistance (>2.0 mm Hg/cm/s), CMED was defined as abnormal acetylcholine-induced per cent change of coronary blood flow (≤50%). Results Patients with high aortic PP had a higher rate of CMEID than those with low aortic PP (40.9 vs 25.2%, p<0.001). Conversely, aortic PP was not associated with CMED. On multivariate analysis, high aortic PP was associated with CMEID occurrence (OR 1.42, 95% CI 1.13 to 1.78; p=0.003). On follow-up (median, 150 months), all-cause death was more frequent among patients with vs without high aortic PP (20.1% vs 7.3%, log-rank p<0.001) and HR was 2.08 (95% CI 1.34 to 3.32, p=0.002) on multivariate cox regression analysis. Furthermore, among patients with low aortic PP, CMEID was an independent risk factor for all-cause mortality (HR 2.04, 95% CI 1.01 to 4.16, p=0.048). Conclusion In patients with non-obstructive CAD, invasive aortic PP was significantly associated with CMEID, but not with CMED. High aortic PP was an independent predictor of all-cause mortality, but CMEID was an independent risk factor in patients with low aortic PP.
Standardizing nomenclature for fascial plane blocks: the destination not the journey
El‐Boghdadly, Kariem , Wolmarans, Morné , Kopp, Sandra L. , Mariano, Edward R. , Elkassabany, Nabil , Kopp, Sandra , Elkassabany, Nabil M , Mariano, Edward R , El-Boghdadly, K , Albrecht, Éric

Mayo Clinic

Regional Anesthesia & Pain Medicine | February 1, 2022 | Volume: 47 | Issue: 5 | Pages: 341.2-342

10.1136/rapm-2021-103457 | PMID 35105723 Get It

Trends in Use of Melatonin Supplements Among US Adults, 1999-2018
Li, Jingen , Xu, Hao , Covassin, Naima , Somers, Virend K. , López-Jiménez, Francisco , Li, Jingen

Mayo Clinic

JAMA | February 1, 2022 | Volume: 327 | Issue: 5 | Pages: 483

10.1001/jama.2021.23652 | PMID 35103775 Get It

How two molecules self-assemble and what accelerates their assembly
Pang, Yuan‐Ping

Mayo Clinic

No container title available | February 1, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.26434/chemrxiv-2021-vkkl4 Get It

Cram’s supramolecular capsule Octacid4 can irreversibly and noncovalently self-assemble with small- molecule guests at room temperature, but how they self-assemble and what accelerates their assembly are open questions that hold the key to developing noncovalent irreversible complexes. This article reports 72 distinct Octacid4•guest self-assembly pathways captured in unrestricted, unbiased, millisecond molecular dynamics simulations, revealing that the self-assembly process was initiated by the guest interaction with the cavity portal exterior of Octacid4 to increase the portal collisions that led to the portal expansion for guest ingress, accelerated by engaging populated host and guest conformations for the exterior interaction to increase the portal collision frequency, and completed by the portal contraction caused by the guest docking inside the cavity to impede guest egress. These revelations explain why the presence of a cryptic exterior binding site at the rim of the enzyme active site is a fundamental feature of fast enzymes such as acetylcholinesterase and why small molecules adopt local minimum conformations when binding to proteins. Furthermore, these revelations suggest that noncovalent irreversible complexes with fast assembly rates could be developed—by engaging populated host and guest conformations during the exterior interactions—for materials technology, data storage and processing, molecular sensing and tagging, and drug therapy.
Rapid Reductions in Breast Density following Tamoxifen Therapy as Evaluated by Whole-Breast Ultrasound Tomography
Gierach, Gretchen L. , Sak, Mark, Fan, Shaoqi , Palakal, Maya, Bey‐Knight, Lisa, Gorski, David H. , Ali, Haythem , Littrup, Peter J. , Duric, Nebojsa , Gorski, David , Fan, Shaoqi , Gierach, Gretchen L , Pfeiffer, Ruth M. , Ramin, Cody A. , Simon, Michael S. , Sherman, Mark E.

Mayo Clinic

Journal of Clinical Medicine | February 1, 2022 | Volume: 11 | Issue: 3 | Pages: 792

10.3390/jcm11030792 | PMID 35160244 Get It

Purpose: Women whose mammographic breast density declines within 12–18 months of initiating tamoxifen for chemoprevention or adjuvant treatment show improved therapeutic responses compared with those whose density is unchanged. We tested whether measuring changes in sound speed (a surrogate of breast density) using ultrasound tomography (UST) could enable rapid identification of favorable responses to tamoxifen. Methods: We evaluated serial density measures at baseline and at 1 to 3, 4 to 6, and 12+ months among 74 women (aged 30–70 years) following initiation of tamoxifen for clinical indications, including an elevated risk of breast cancer (20%) and diagnoses of in situ (39%) or invasive (40%) breast carcinoma, enrolled at Karmanos Cancer Institute and Henry Ford Health System (Detroit, MI, USA). For comparison, we evaluated an untreated group with screen negative mammography and frequency-matched on age, race, and menopausal status (n = 150), at baseline and 12 months. Paired t-tests were used to assess differences in UST sound speed over time and between tamoxifen-treated and untreated patients. Results: Sound speed declined steadily over the 12 month period among patients receiving tamoxifen (mean (SD): −3.0 (8.2) m/s; p = 0.001), whereas density remained unchanged in the untreated group (mean (SD): 0.4 (7.1) m/s; p = 0.75 (relative change between groups: p = 0.0009)). In the tamoxifen group, we observed significant sound speed reductions as early as 4–6 months after tamoxifen initiation (mean (SD): −2.1 (6.8) m/s; p = 0.008). Sound speed reductions were greatest among premenopausal patients (P-interaction = 0.0002) and those in the middle and upper tertiles of baseline sound speed (P-interaction = 0.002). Conclusions: UST can image rapid declines in sound speed following initiation of tamoxifen. Given that sound speed and mammographic density are correlated, we propose that UST breast imaging may capture early responses to tamoxifen, which in turn may have utility in predicting therapeutic efficacy.
Early Post-Hospitalization Hemoglobin Recovery and Clinical Outcomes in Survivors of Critical Illness: A Population-Based Cohort Study
Warner, Matthew A. , Hanson, Andrew C. , Schulte, Phillip J. , Roubinian, Nareg H. , Storlie, Curt B., Demuth, Gabriel , Kor, Daryl J. , Storlie, Curt, Warner, Matthew A , Gajic, Ognjen

Mayo Clinic

Journal of Intensive Care Medicine | February 1, 2022 | Volume: 37 | Issue: 8 | Pages: 1067-1074

10.1177/08850666211069098 | PMID 35103495 Get It

Anemia is common during critical illness, is associated with adverse clinical outcomes, and often persists after hospitalization. The goal of this investigation is to assess the relationships between post-hospitalization hemoglobin recovery and clinical outcomes after survival of critical illness. This is a population-based observational study of adults (≥18 years) surviving hospitalization for critical illness between January 1, 2010 and December 31, 2016 in Olmsted County, Minnesota, United States with hemoglobin concentrations and clinical outcomes assessed through one-year post-hospitalization. Multi-state proportional hazards models were utilized to assess the relationships between 1-month post-hospitalization hemoglobin recovery and hospital readmission or death through one-year after discharge. Among 6460 patients that survived hospitalization for critical illness during the study period, 2736 (42%) were alive, not hospitalized, and had available hemoglobin concentrations assessed at 1-month post-index hospitalization. Median (interquartile range) age was 69 (56, 80) years with 54% of male gender. Overall, 86% of patients had anemia at the time of hospital discharge, with median discharge hemoglobin concentrations of 10.2 (9.1, 11.6) g/dL. In adjusted analyses, each 1 g/dL increase in 1-month hemoglobin recovery was associated with decreased instantaneous hazard for hospital readmission (HR 0.87 [95% CI 0.84-0.90]; p < 0.001) and lower mortality (HR 0.82 [95% CI 0.75-0.89]; p < 0.001) through one-year post-hospitalization. The results were consistent in multiple pre-defined sensitivity analyses. Impaired early post-hospitalization hemoglobin recovery is associated with inferior clinical outcomes in the first year of survival after critical illness. Additional investigations are warranted to evaluate these relationships.
Recommended Musculoskeletal and Sports Ultrasound Terminology: A Delphi‐Based Consensus Statement
Hall, Mederic M. , Allen, Georgina , Allison, Sandra J. , Craig, Joseph G. , DeAngelis, Joseph P. , Delzell, Patricia B. , Finnoff, Jonathan T. , Gupta, Atul , Hoffman, Douglas F. , Nazarian, Levon N. , Onishi, Kentaro , Ray, Jeremiah W. , Smith, Jay , Tagliafico, Alberto , Allen, Georgina M , Allison, Sandra , Craig, Joseph , Frank, Rachel M , Gupta, Atul , Hoffman, Douglas F , Jacobson, Jon A , Narouze, Samer , Nazarian, Levon N , Onishi, Kentaro , Ray, Jeremiah W , Sconfienza, Luca M , Smith, Jay , Tagliafico, Alberto , Finnoff, Jonathan T , Jacobson, Jon A. , Narouze, Samer

Mayo Clinic

Journal of Ultrasound in Medicine | February 1, 2022 | Volume: 41 | Issue: 10 | Pages: 2395-2412

10.1002/jum.15947 | PMID 35103998 Get It

Objectives The current lack of agreement regarding standardized terminology in musculoskeletal and sports ultrasound presents challenges in education, clinical practice, and research. This consensus was developed to provide a reference to improve clarity and consistency in communication. Methods A multidisciplinary expert panel was convened consisting of 18 members representing multiple specialty societies identified as key stakeholders in musculoskeletal and sports ultrasound. A Delphi process was used to reach consensus which was defined as group level agreement >80%. Results Content was organized into seven general topics including: 1) General Definitions, 2) Equipment and Transducer Manipulation, 3) Anatomic and Descriptive Terminology, 4) Pathology, 5) Procedural Terminology, 6) Image Labeling, and 7) Documentation. Terms and definitions which reached consensus agreement are presented herein. Conclusions The historic use of multiple similar terms in the absence of precise definitions has led to confusion when conveying information between colleagues, patients, and third‐party payers. This multidisciplinary expert consensus addresses multiple areas of variability in diagnostic ultrasound imaging and ultrasound‐guided procedures related to musculoskeletal and sports medicine.
Is the presence of tumor‐infiltrating lymphocytes predictive of outcomes in patients with melanoma?
Morrison, S. , Vetto, John T. , Fowler, Graham, Leong, Stanley P. L. , Kashani–Sabet, Mohammed , Pockaj, Barbara A. , Sondak, Vernon K. , Messina, Jane L. , Mozzillo, Nicola, Schneebaum, Schlomo , Han, Dale , Group, for the Sentinel Lymph Node Working, Morrison, Steven L , Kashani-Sabet, Mohammed , Sondak, Vernon K , Han, Gang , Elenwa, Faith , Kosiorek, Heidi , Zager, Jonathan S. , Group, for the Sentinel Lymph Node Working

Mayo Clinic

Cancer | February 1, 2022 | Volume: 128 | Issue: 7 | Pages: 1418-1428

10.1002/cncr.34013 | PMID 35103302 Get It

BackgroundThe significance of tumor‐infiltrating lymphocytes (TILs) in melanoma is debated. This article presents a multicenter, retrospective study assessing the predictive and prognostic value of TILs.MethodsThe Sentinel Lymph Node Working Group database was queried from 1993 to 2018 for cases with known TIL data. TILs were categorized as absent or present, which included nonbrisk (NB), brisk (B), and present but unspecified TIL levels. Clinicopathologic factors were correlated with TILs, sentinel lymph node (SLN) status, and melanoma‐specific survival (MSS).ResultsOverall, 3203 patients were included. The median thickness was 1.5 mm, and 469 cases had SLN metastases. TILs were present in 2458 cases (76.7%), with NB, B, and unspecified TILs seen in 1691 (68.8%), 691 (28.1%), and 76 (3.1%), respectively. Multivariable analysis showed that the presence of TILs significantly predicted a negative SLN biopsy (P < .05). The median follow‐up was 25.2 months. MSS was significantly better for cases with TILs than cases without TILs (P < .001). According to multivariable analysis, age, gender, thickness, mitotic rate, ulceration, lymphovascular invasion, and SLN status were significantly prognostic of MSS (all P values < .05). Although TILs were not prognostic of MSS, when multiple imputation was used and the SLN status was excluded, the presence of TILs was significantly prognostic of improved MSS (hazard ratio, 0.78; 95% confidence interval, 0.64‐0.95; P = .0154).ConclusionsTILs are a favorable marker because their presence significantly predicts a negative SLN, and the absence of TILs may be a prognostic marker of worse survival in patients with a positive SLN but not a negative SLN. TILs may also serve as a prognostic marker of survival when the SLN status is not considered.
A Tri-Layered Hydrogel Scaffold for Vocal Fold Tissue Engineering
Tindell, R. Kevin, McPhail, Michael J., Neubauer, Juergen, Myers, Cheryl , Hintze, Justin , Lott, David G. , Holloway, Julianne L.

Mayo Clinic

No container title available | February 1, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.26434/chemrxiv-2021-d6cqz Get It

The lamina propria within the vocal fold (VF) is a complex multi-layered tissue that increases in stiffness from the superficial to deep layer, where this characteristic is crucial for VF sound production. Tissue engineered scaffolds designed for VF repair must mimic the biophysical nature of the native vocal fold and promote cell viability, cell spreading, and vibration with air flow. In this study, we present a unique tri-layered, partially-degradable hydrogel scaffold that mimics the multi-layered structure of the VF lamina propria. Using thiol-norbornene photochemistry, tri-layered hydrogel scaffolds were fabricated via layer-by-layer stacking with increasing polymer concentration from the top to middle to deep layer. Mechanical analysis confirmed hydrogel modulus increased with increasing polymer concentration. Partially-degradable hydrogels promoted high cell viability and cell spreading in 3D as assessed via live/dead and cytoskeleton staining, respectively. Importantly, partially-degradable hydrogels maintained some degree of the 3D polymer network following protease exposure, while still enabling encapsulated cells to remodel their local environment via protease secretion. Finally, the tri-layered hydrogel scaffold successfully vibrated and produced sound in proof-of-concept air flow studies. This work represents a critical first step towards the design of a multi-layered, hydrogel scaffold for vocal fold tissue engineering.
A Pragmatic Approach to the Evaluation and Treatment of Abdominal Bloating
Lacy, Brian E. , Cangemi, David J.

Mayo Clinic

American Journal of Gastroenterology | February 1, 2022 | Volume: 117 | Issue: 5 | Pages: 701-705

10.14309/ajg.0000000000001665 | PMID 35103019 Get It